$9.54
▲ $0.21 (+2.3%)
IMMX
Immix Biopharma Inc. Common Stock
Health Care
Investor Score
47D+
Moderate rating
Based on 6 of 7 weighted categories, computed from real, live financial data only.
59
Technical
46
Fundamental
32
Growth
38
Fair Value
50
News
—
Quality
48
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.